Tesamorelin activates the GHRH receptor (a class B G-protein-coupled receptor), triggering a cAMP-PKA signaling cascade that upregulates growth hormone gene transcription and increases somatotroph sensitivity to subsequent secretagogue signals
Molecular Properties Property Value Systematic Name Aib-His-D-2-Nal-D-Phe-Lys-NH Molecular Formula CHNO Molecular Weight 711.85 Da CAS Number 170851-70-4 Structure Class Synthetic pentapeptide Receptor Target GHS-R1a (growth hormone secretagogue receptor type 1a) Development Novo Nordisk (NNC 26-0161) The sequence includes -aminoisobutyric acid (Aib) at position 1, D-2-naphthylalanine (D-2-Nal) at position 3, and D-phenylalanine (D-Phe) at position 4
You can apply them each on their own, or use them in sequence (01 02 03) depending on your skins current needs giving you flexibility for targeted care
CJC1295 has an identical effect as GHRH actions and can alter hypothalamic feedback by increasing IGFI
Its important to note that this does not mean NAD+ supplements cause cancer
Meanwhile, in a H 2 O 2 -induced zebrafish model, butin reduced the levels of reactive oxygen species in vivo (Lai et al., 2021)
